Clarity Pharmaceuticals Ltd
CU6.AX
Australian Securities Exchange2.46
AUD
-0.17
- -
Total Valuation
Clarity Pharmaceuticals Ltd carries a market capitalization of 917.78M, placing it among publicly traded companies globally.
| Market Cap | 917.78M |
| Enterprise Value | N/A |
Stock Price Statistics
Clarity Pharmaceuticals Ltd's stock has declined approximately -10.54545% over the past 52 weeks. The 50-day moving average sits at 2.48, while the 200-day moving average is 3.36.
| Beta (5Y) | N/A |
| 52-Week Price Change | -10.54545% |
| 50-Day Moving Average | 2.48 |
| 200-Day Moving Average | 3.36 |
| Average Volume (20 Days) | N/A |
Stock Splits
Clarity Pharmaceuticals Ltd's most recent stock split took place on March 27, 2024 with a 1000:1003 split ratio.
| Last Split Date | 3/27/2024 |
| Split Ratio | 1000:1003 |